Author

Xueying Lai

Observed name: Xue-Ying Lai

Institutions: Panyu District Central Hospital, Guangzhou Medical University

Observed institutions: Nanfang Hospital, Panyu District Central Hospital, Southern Medical University Shenzhen Hospital, Southern Medical University, Guangzhou Medical University

ORCID: 0009-0008-1912-0615

Observed ORCID: 0009-0008-1912-0615

OpenAlex ID: A5047467688

Metformin protects against intestinal barrier dysfunction via AMPKα1‐dependent inhibition of JNK signalling activation

2017 · Jun Deng, Lishan Zeng, et al. · Journal of Cellular and Molecular Medicine · 130

Metformin alleviates colitis-associated colorectal cancer via inhibition of the TLR4/MyD88/NFκB/MAPK pathway and macrophage M2 polarization

2024 · Xueying Lai, Bin Liu, et al. · International Immunopharmacology · 25

Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier

2024 · Xueying Lai, Hong Zhou, et al. · International Immunopharmacology · 12

[Risk factors of pain during colonoscopic examination].

2016 · Xue-Ying Lai, Xiao-Wei Tang, et al. · Europe PMC (PubMed Central) · 6

Therapeutic effect of indirubin-loaded bovine serum albumin nanoparticules on ulcerative colitis

2022 · Guang-Min Yu, Li-Feng Zhou, et al. · Biomaterials Science · 5

Treatment of colitis cystica profunda via endoscopic submucosal dissection

2025 · Xueying Lai, Yiwei He, et al. · Endoscopy · 1

Works count: 6

Citation count: 179

H-index: 5

I10-index: 3